Anuncio • 7h
Light AI Inc. announced that it expects to receive CAD 5 million in funding Light AI Inc. announced a private placement with MV Capital LP to issue 5,000 secured convertible debenture units at an issue price of CAD 1,000 for the proceeds of CAD 5,000,000 on May 21, 2026. Each Unit will comprise of (i) a 12.0% secured convertible debenture of the Company in the principal amount equal to CAD 1,000 (each, a "Convertible Debenture") with interest compounded quarterly and payable on the earlier of the Maturity Date (as defined hereafter), prepayment or conversion and maturing 24 months from the closing of the Financing (the "Maturity Date"), and (ii) 8,000 common share purchase warrants (each, a "Warrant"), each Warrant being exercisable for a period of 36 months following the closing of the Financing (the "Closing Date") to purchase one common share of the Company (each, a "Warrant Share") at an exercise price of CAD 0.25 per Warrant Share. The Financing is expected to close on or around June 19, 2026, and is subject to certain closing conditions including, but not limited to, the receipt of all necessary regulatory and stock exchange approvals, including the approval of the Exchange. New Risk • May 13
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Canadian stocks, typically moving 18% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CA$11m free cash flow). Share price has been highly volatile over the past 3 months (18% average weekly change). Earnings have declined by 53% per year over the past 5 years. Revenue is less than US$1m. Minor Risk Market cap is less than US$100m (CA$19.6m market cap, or US$14.3m). New Risk • Jan 07
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: CA$12.8m (US$9.29m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CA$12m free cash flow). Earnings have declined by 59% per year over the past 5 years. Revenue is less than US$1m. Market cap is less than US$10m (CA$12.8m market cap, or US$9.29m). Minor Risk Share price has been volatile over the past 3 months (17% average weekly change). Anuncio • Dec 05
Light AI Inc. Announces Transition Of Anthony Schaller From President And Chief Technology Officer To Advisory Role Light AI Inc. announced that the Company's President and Chief Technology Officer, Mr. Anthony Schaller, has transitioned from the Company's President and Chief Technology Officer to an advisory role. Mr. Schaller has been instrumental in leading the Company's product development initiatives since late 2024 culminating with the Company's first version of its commercially oriented software completion. The Company is now transitioning to focus on its regulatory and commercialization initiatives. Anuncio • Nov 19
Light AI Inc. Announces the Completion of Version 1.0 of its Commercial Software Platform Light AI Inc. announced the completion of Version 1.0 of its commercial software platform. The software leverages proprietary AI algorithms to analyze smartphone images--initially focused on detecting Group A Streptococcus ("Strep A")--delivering rapid, accurate results without the need for swabs or lab tests. The app-based solution is designed for use on both iOS and Android devices, enabling broad accessibility and scalability. Light AI plans to initiate a pilot study with a major global healthcare provider to confirm the performance in managing pharyngitis cases in a real-world clinical urgent care medical setting. The pilot is expected to pave the way for initial anticipated commercial distribution and global expansion. Beyond pharyngitis, Light AI's platform is designed to expand into other diagnostic areas, including eye and skin conditions. The Company's broader vision is to create a cloud-based "Digital Clinical Lab" that transforms smartphones into accessible diagnostic tools, reducing reliance on traditional lab infrastructure. Anuncio • Oct 22
Light AI Inc. Announces Board Changes Light AI Inc. announced the appointment of two new directors to its board of directors, Mr. Robert Cartagena and Mr. Mario Vetro. Robert Cartagena is co-founder and managing partner of Mill Street Equity Partners LLC (formerly Mill Street Partners LLC), a specialty investment strategy development firm focused on middle-market dental and medical device companies. Robert had a 33-year career as a C-level executive and or board member for various dental manufacturing companies including Discus Dental LLC and DenMat Holdings LLC, serving as Chief Operating Officer for each firm. At both companies Robert led the development and launch of products which are now household brands in the dental industry in product categories such as surgical lasers, dental materials, professional teeth whitening, magnification and more. He has created tremendous value at various companies through new product development, sales and marketing, as well as buy-side and sell-side M&A in both private and public environments. Mario Vetro brings substantial expertise in structuring and raising capital for growth companies with a focus on technology and the natural resources sector. He currently serves as CEO of Commodity Partners Inc, a boutique merchant bank and advisory firm. There, he played a pivotal role in the co-founding of K92 Mining Inc., a company listed on the TSX, leading to the establishment of a world-class gold discovery and mining operation in Papua New Guinea. Building upon this success, Mr. Vetro excels at assembling formidable leadership teams, securing equity capital, and devising strong business strategies. The Company also announced the Mr. Hugh Cleland is transitioning from the Company's Board of Directors due to health reasons. Mr. Cleland has been instrumental in the Company's transition to a public company and supporting the Company in its financing and investor relations initiatives. Anuncio • Sep 05
Light AI Inc. Announces Transition of Thomas Scarnecchia from Chief Operating Officer to an Advisory Role, Effective September 1, 2025 Light AI Inc. announced the transition of its Chief Operating Officer ("COO"), Thomas Scarnecchia, to an advisory role primarily supporting the Company's regulatory initiatives effective September 1, 2025. Anuncio • Jul 08
Light Ai Inc. Achieves Key Internal Milestones in the Development of Its Wellness Strep A Screening Application Light AI Inc. announced that it has achieved key internal milestones in the development of its Wellness Strep A screening application. The Company's AI powered software platform is currently undergoing internal user testing by Light AI and its low and middle income countries go-to-market partner, Tech Care For All. The Company continues to progress with its initial commercialization efforts for its Wellness Application, inclusive of potential targeted market-demonstration deployments with pharmacy companies. Commercial availability of the Company's Wellness Application remains targeted for late 2025. The global AI healthcare market is projected to reach USD 110.6 billion by 2030 from USD 21.7 billion in 2025, at a CAGR of approximately 39% based upon adoption to new AI health and wellness solutions. The market is anticipated to grow due to the growing investments & funding by public-private organizations, the fast proliferation of AI in the healthcare industry, and the rising focus on developing human-aware AI systems. The market is experiencing growth due to increasing demand for enhanced services due to an unequal ratio between the healthcare workforce and patient numbers. However, inadequate IT infrastructure and inability to adopt AI-based healthcare solutions in emerging economies are estimated to pose a challenge to market growth to be addressed. New Risk • May 16
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -CA$11m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CA$11m free cash flow). Share price has been highly volatile over the past 3 months (26% average weekly change). Earnings have declined by 58% per year over the past 5 years. Revenue is less than US$1m. Minor Risk Market cap is less than US$100m (CA$43.9m market cap, or US$31.4m). Anuncio • May 02
Light AI Inc. Moves Forward on Third 2025 Wellness Commercialization Plan Light AI Inc. announced that it continues to make solid progress towards its Wellness App Third Quarter 2025 commercialization consistent with the Company's prior announcement. Progress is being made on the Wellness App's innovative and intuitive UI design which will provide a seamless and empowering user experience. The Company anticipates showcasing a closed demo of its Wellness App within approximately 90 days to support its pre-commercialization initiatives. Built with experienced oversight and cutting-edge design principles at its core the AI oriented UI offers a seamless, beautifully easy to use navigation experience. Every touchpoint has been designed, reviewed, debated and engineered to make it easy for users to indicate their symptoms of concern, move to a scan, and quickly receive feedback with recommended next steps. Highlights of the Wellness App UI include: Streamlined Navigation - Clear map of the journey along with simplified menus create an experience easy for users to navigate; Cross-platform consistency - Whether users are on an IOS or Android device, the experience remains consistent and engaging; Personalized History and Resources - Users can see prior results and build a baseline of scan results, healthy or in response to reported symptoms; and Vibrant, Engaging Intuitive Visuals - The vibrant colour palette and typography promote a sense of calm, engagement and positivity. The innovative and intuitive UI design will roll out to users in a staggered release to allow time for feedback and improvement before full commercial launch anticipated in late 2025. Anuncio • Apr 17
Light AI Inc. Auditor Raises 'Going Concern' Doubt Light AI Inc. filed its Annual on Apr 15, 2025 for the period ending Dec 31, 2024. In this report its auditor, SHIM & Associates LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern. Anuncio • Apr 16
Light AI Inc. Announces Expansion of Its Wellness Platform Light AI Inc. announced that its innovative wellness platform, anticipated to launch in Third Quarter of 2025, is expanding its capabilities to help users rule out COVID-19 and conjunctivitis (pink eye) in addition to Strep A. The wellness platform is a direct-to-consumer product designed to support the quick detection and management of these conditions and will serve as a cornerstone in Light AI's expanding suite of healthcare tools aimed at supporting millions of families and individuals worldwide. These additional medical conditions expand Light AI's addressable market and are anticipated to enhance revenue and opportunities for licensing and partnership. This illustrates the Company's progress toward its ultimate goal of being a one-stop application to enhance health and wellness. Group A Strep, a common yet potentially serious infection, can cause significant health complications if not managed properly. Light AI's app will leverage advanced machine learning (ML) algorithms to provide accurate and timely diagnosis, empowering families to manage this condition more effectively. Conjunctivitis is a highly infectious condition affecting approximately 6 million people annually in the USA alone, and can lead to severe complications such as cellulitis, orbital cellulitis, keratitis, corneal ulcers, and scarring, potentially increasing the risk of permanent vision impairment if left untreated. Light AI's dedicated team is currently working to advance diagnostics on healthcare issues and will provide updates as new algorithms are refined. This expanded ecosystem will not only provide economies of scale to support market demand but will also generate valuable data to enhance predictive algorithms for future healthcare solutions. Anuncio • Apr 01
Light Ai Inc. Appoints Anthony Schaller as President and CTO Light AI Inc. announce the appointment of Anthony Schaller as the new President and CTO. Mr. Schaller is a globally recognized leader in the technology industry. Since October 2024, Mr. Schaller has been assessing and planning Light AI's app platform and cloud-based development activities, driving Light AI's technology road map and related commercialization initiatives. Four Decades Of Development Experience Mr. Schaller has four decades of extensive experience in global strategy, innovation, research and development, and product and technology development and commercialization across enterprise and consumer markets in North America including: Creating and implementing the platform for digital media distribution to portable music devices as well as in the home, inclusive of the MPEG-1 Audio Layer 3 (MP3) player and Advanced Audio Coding (AAC) industry file format to compress and store audio; Leading technology innovation and transformation efforts at CitySearch /Ticketmaster; Leader in chemical R&D solving the problem of database access in different formats and systems enabling global pharmaceutical researchers to accelerate drug discovery; Led pioneering development of distributed databases and file systems starting with the Andrew Project at Carnegie Mellon University (CMU) and Ingres; Led technology scale-up and commercialization of Match.com (pioneer internet-based dating site), responsible for approximately 40x increase in user traffic and a 10x increased market capitalization, resulting in a buyout; and Senior Operating advisor for a global private equity firm with over $60 billion in assets under management providing operational strategy, SaaS transformation of process and products, margin efficiency /improvement leadership as well as due diligence on strategic acquisitions. Anuncio • Feb 06
Light AI Inc. Announces Appointments to Advisory Board Light AI Inc. announced its Advisory Board. The Advisory Board has been designed to accelerate Light AI's goal of becoming a leader in the global AI healthcare market and will provide oversight and strategic guidance, advise on go-to-market strategies, and collaborate closely with the Company's leadership team and board of directors (the "Board"). The distinguished members of Light AI's Advisory Board include: Yu Zhao Yu Zhao is the President of Bridging Consulting LLC, a boutique regulatory firm supporting AI startups and medical device companies. With 16 years of leadership experience at Medtronic, including roles as Director and Interim VP of Regulatory Affairs, Mr. Zhao offers expert insights into navigating complex regulatory landscapes. Over the course of his career, Mr. Zhao and his teams have secured more than 150 U.S. FDA approvals and clearances, spanning PMAs, PMA supplements, IDEs, 510(k)s, and De Novos, for a wide range of devices—from implantable devices to deep learning algorithms. Raymond Ng Raymond Ng is a Professor of Computer Science at the University of British Columbia and the Director of the Data Science Institute. Mr. Ng is a recognized authority in Machine Learning and Data Science, contributing invaluable expertise to the advisory committee. He has published over 250 refereed articles on diverse topics related to data science. He is the Canada Research Chair on data science and analytics, and an elected fellow of the Royal Society of Canada. For both 2022 and 2023, he was named one of the world's top-75 academic data science leaders by the MIT-based CDO magazine. David Talan Dr. David A. Talan is board-certified in Internal Medicine, Emergency Medicine, and Infectious Diseases, and serves as Professor of Medicine in Residence (Emeritus) at UCLA and the University of Iowa. He has chaired the Olive View-UCLA Department of Emergency Medicine and is currently on the faculty at UCLA Ronald Reagan Medical Center. Dr. Talan's research focuses on acute infections, emergency department-based surveillance, and epidemiological research of emerging infections. He has numerous publications in prestigious journals, and his work has significantly influenced the management of infectious diseases. David Bell David Bell is a public health physician and expert in infectious disease diagnostics. Formerly leading malaria diagnostics coordination at the WHO, Programme Head of Malaria & Acute Febrile Disease at the Foundation for Innovative New Diagnostics (FIND), and Director of Global Health Technologies at Intellectual Ventures Global Good Fund, he now consults in global health and biotech, driving impactful solutions in global health. Anuncio • Jan 28
Light AI Inc. Announces the Appointment of George Reznik to Corporate Secretary Light AI Inc. announced the appointment of George Reznik to Corporate Secretary effective January 27, 2025. Mr. Reznik has extensive expertise in international corporate finance, strategic business planning, mergers and acquisitions, business restructuring and growth management, investor relations, and operational management. Mr. Reznik is formerly the CFO of Tantalus Systems. Prior to joining Tantalus, Reznik was CFO and Corporate Secretary of Intrinsyc Technologies until its successful acquisition by Lantronix, CFO of DDS Wireless, CFO and COO of Infowave Software, and the Vice President of Finance at Pivotal Corporation where he played a leadership role through its IPO on the Nasdaq and its subsequent rapid business and revenue growth from USD 10 million to over USD 140 million over a three year period. Mr. Reznik previously was the Corporate Finance Valuation Practice Leader of Deloitte based in Canada and the UK. Mr. Reznik is a Chartered Professional Accountant - Chartered Accountant (CPA, CA), a Chartered Business Valuator (CBV), a Certified Fraud Examiner (CFE) and holds a Bachelor of Commerce (Honors) degree from the University of Manitoba. He is the Chair of the BC Hi Tech CFO C-Council and was the recipient of the BC Public Company CFO of the Year award. Board Change • Jan 09
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment. Anuncio • Jan 01
Mojave Brands Inc. has completed a Composite Units Offering in the amount of CAD 16.0864 million. Mojave Brands Inc. has completed a Composite Units Offering in the amount of CAD 16.0864 million.
Security Name: Units
Security Type: Equity/Derivative Unit
Securities Offered: 29,248,000
Price\Range: CAD 0.55
Discount Per Security: CAD 0.0385
Security Name: Warrant
Security Type: Equity Warrant
Securities Offered: 14,624,000
Security Name: Units
Security Type: Equity/Derivative Unit
Price\Range: CAD 0.55
Discount Per Security: CAD 0.01925 